Petasins in the treatment of allergic diseases: Results of preclinical and clinical studies

International Archives of Allergy and Immunology

Volumn 129, Issue 2, 2002, Pages 108-112

  Thomet, O A R ^a,b   Simon, Hans Uwe ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b GlaxoSmithKline   (Switzerland)

Author keywords

Allergic rhinitis; Antihistamines; Cetirizine; Isopetasin; Leukotriene receptor antagonists; Leukotrienes; Neopetasin; Petasin; Petasites hybridus

Indexed keywords

HISTAMINE; HISTAMINE H1 RECEPTOR ANTAGONIST; ISOPETASIN; LEUKOTRIENE; NEOPETASIN; PETASIN; PETASITES HYBRIDUS EXTRACT; PLANT EXTRACT; SESQUITERPENE DERIVATIVE; UNCLASSIFIED DRUG;

ALLERGIC DISEASE; ALLERGIC RHINITIS; ANTIINFLAMMATORY ACTIVITY; CELL FUNCTION; CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG MECHANISM; DRUG TARGETING; EFFECTOR CELL; EOSINOPHIL; FATIGUE; HISTAMINE RELEASE; HUMAN; IN VITRO STUDY; INFLAMMATORY CELL; LEUKOCYTE; NOSE MUCUS; PRIORITY JOURNAL; REVIEW;

ASTERACEAE; EOSINOPHILS; HISTAMINE ANTAGONISTS; HUMANS; LEUKOTRIENES; PHYTOTHERAPY; PLANT EXTRACTS; PROSTAGLANDINS; RECEPTORS, HISTAMINE H1; RHINITIS, ALLERGIC, PERENNIAL; SESQUITERPENES;

EID: 0036979885     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000065884     Document Type: Review

References (46)

1. Parikh A, Scadding GK: Seasonal allergic rhinitis. BMJ 1997;314:1392-1395.
2. Bousquet J, Duchateau J, Pignat JC, Fayol C, Marquis P, Mariz S, Ware JE, Valentin B, Burtin B: Improvement of quality of life by treatment with cetirizine in patients with perennial allergic rhinitis as determined by a French version of the SF-36 questionnaire. J Allergy Clin Immunol 1996;98:309-316.
3. Juniper EF: Measuring health-related quality of life in rhinitis. J Allergy Clin Immunol 1997; 99:S742-S749.
4. Klimek L, Wolf H, Mewes T, Dormann D, Reske-Kunz A, Schnitker J, Mann W: The effect of short-term immunotherapy with molecular standardized grass and rye allergens on eosinophil cationic protein and tryptase in nasal secretions. J Allergy Clin Immunol 1999; 103:47-53.
5. Togias AG, Naclerio RM, Peters SP, Nimmagadda I, Proud D, Kagey-Sobotka A, Adkinson NF, Norman PS, Lichtenstein LM: Local generation of sulfidopeptide leukotrienes upon nasal provocation with cold, dry air. Am Rev Respir Dis 1986;133:1133-1137.
6. Knapp HR: Reduced allergen-induced nasal congestion and leukotriene synthesis with an orally active 5-lipoxygenase inhibitor. N Engl J Med 1990;323:1745-1748.
7. 4 induced hyperadhesiveness of endothelial cells for neutrophils. J Immunol 1994;152:262-269.
8. 4. Eur Respir J 2000;15:274-280.
9. Di Lorenzo G, Mansueto P, Melluso M, Candore G, Colombo A, Pellitteri ME, Drago A, Potestio M, Caruso C: Allergic rhinitis to grass pollen: Measurement of inflammatory mediators of mast cell and eosinophils in native nasal fluid lavage and in serum out of and during pollen season. J Allergy Clin Immunol 1997;100:832-837.
10. 4 hydrolase in human leukocytes. Purification and properties. J Biol Chem 1984;259:12339-12345.
11. 4. Proc Natl Acad Sci USA 1983;80:7626-7630.
12. Glaser KB, Sung A, Bauer J, Weichman BM: Regulation of eicosanoid biosynthesis in the macrophage. Involvement of protein tyrosine phosphorylation and modulation by selective protein tyrosine kinase inhibitors. Biochem Pharmacol 1993;45:711-721.
13. Lewis RA, Austen KF, Soberman RJ: Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. N Engl J Med 1990;323:645-655.
14. Simon HU, Weber M, Becker E, Zilberman Y, Blaser K, Levi-Schaffer F: Eosinophils maintain their capacity to signal and release eosinophil cationic protein upon repetitive stimulation with the same ligand. J Immunol 2000; 165:4069-4075.
15. Rothenberg ME, Owen WFJ, Silberstein DS, Soberman RJ, Austen KF, Stevens RL: Eosinophils cocultured with endothelial cells have increased survival and functional properties. Science 1987;237:645-647.
16. Takafuji S, Bischoff SC, De Weck AL, Dahinden CA: IL-3 and IL-5 prime normal human eosinophils to produce leukotriene C4 in response to soluble agonists. J Immunol 1991; 147:3855-3861.
17. Dahinden CA, Zingg J, Maly FE, De Weck AL: Leukotriene production in human neutrophils primed by recombinant human granulocyte/macrophage colony-stimulating factor and stimulated with the complement component C5A and FMLP as second signals. J Exp Med 1988;167:1281-1295.
18. Bischoff SC, De Weck AL, Dahinden CA: Interleukin 3 and granulocyte/macrophage colony-stimulating factor render human basophils responsive to low concentrations of complement component C3a. Proc Natl Acad Sci USA 1990;87:6813-6817.
19. Brock TG, McNish RW, Coffey MJ, Ojo TC, Phare SM, Peters-Golden M: Effects of granulocyte-macrophage colony-stimulating factor on eicosanoid production by mononuclear phagocytes. J Immunol 1996;156:2522-2527.
20. 4 synthesis. J Immunol 1988;140:4315-4322.
21. Zhu X, Birnbaumer L: G protein subunits and the stimulation of phospholipase C by Gs- and Gi-coupled receptors: Lack of receptor selectivity of Galpha(16) and evidence for a synergic interaction between Gbeta gamma and the alpha subunit of a receptor activated G protein. Proc Natl Acad Sci USA 1996;93:2827-2831.
22. 2 contains a Ca(2+)-dependent translocation domain with homology to PKC and GAP. Cell 1991;65:1043-1051.
23. 2 activation. J Leukoc Biol 1999;65:330-336.
24. Rouzer CA, Kargman S: Translocation of 5-lipoxygenase to the membrane in human leukocytes challenged with ionophore A23187. J Biol Chem 1988;263:10980-10988.
25. Cowburn AS, Holgate ST, Sampson AP: IL-5 increases expression of 5-lipoxygenase-activating protein and translocates 5-lipoxygenase to the nucleus in human blood eosinophils. J Immunol 1999;163:456-465.
26. Debrunner B, Meier B:Petasites hybridus: A tool for interdisciplinary research in phytotherapy. Pharm Acta Helv 1998;72:359-362.
27. Lin YL, Mei CH, Hung SL, Kuo YH: Four new sesquiterpenes from Petasites formosanus. J Nat Prod 1998;61:887-890.
28. Scheidegger C, Dahinden C, Wiesmann U: Effects of extracts and of individual components from petasites on prostaglandin synthesis in cultured skin fibroblasts and on leucotriene synthesis in isolated human peripheral leucocytes. Pharm Acta Helv 1998;72:376-378.
29. 1 receptors. Pharm Acta Helv 1998;72:373-375.
30. Thomet OAR, Wiesmann UN, Schapowal A, Blaser K, Simon HU: Role of petasin in the potential anti-inflammatory activity of a plant extract of Petasites hybridus. Biochem Pharmacol 2001;61:1041-1047.
31. Thomet OAR, Wiesmann UN, Blaser K, Simon HU: Differential inhibition of inflammatory effector functions by petasin, isopetasin and neopetasin in eosinophils. Clin Exp Allergy 2001;31:1310-1320.
32. Ziolo G, Samochowiec L: Study on clinical properties and mechanisms of action of petasites in bronchial asthma and chronic obstructive bronchitis. Pharm Acta Helv 1998;72: 378-379.
33. Schapowal A on behalf of Petasites Study Group: Randomised controlled trial of butterbur and ceterizine for treating seasonal allergic rhinitis. BMJ 2002;324:144-146.
34. Thomet OAR, Schapowal A, Heinisch IVWM, Wiesmann UN, Simon HU: Anti-inflammatory activity of an extract of Petasites hybridus in allergic rhinitis. Int Immunopharmacol 2002; 2:997-1006.
35. Bucher K: Über ein antispastisches Prinzip in Petasites officinalis Mönch. Arch Exp Pathol Pharmakol 1951;213:69-71.
36. Ko WC, Lei CB, Lin YL, Chen CF: Relaxant effects of petasins in isolated guinea pig trachea and their structure-activity relationships. Planta Med 2000;66:650-652.
37. Brune K, Bickel D, Peskar BA: Gastro-protective effects by extracts of Petasites hybridus: The role of inhibition of peptido-leukotriene synthesis. Planta Med 1993;59:494-496.
38. Bickel D, Röder T, Bestman HJ, Brune K: Identification and characterization of inhibitors of peptido-leukotriene synthesis from Petasites hybridus. Planta Med 1994;60:318-322.
39. Ko WC, Lei CB, Lin YL, Chen CF: Mechanisms of relaxant action of s-petasin and s-isopetasin, sesquiterpenes of Petasites formosanus, in isolated guinea pig trachea. Planta Med 2001;67:224-229.
40. Wang GJ, Shum AY, Lin YL, Liao JF, Wu XC, Ren J, Cen CF: Calcium channel blockade in vascular smooth muscle cells: Major hypotensive mechanism of s-petasin, a hypotensive sesquiterpene from Petasites formosanus. J Pharmacol Exp Ther 2001;297:240-246.
41. Oehling AG, Akdis CA, Schapowal A, Blaser K, Schmitz M, Simon HU: Suppression of the immune system by oral glucocorticoid therapy in bronchial asthma. Allergy 1997;52:144-154.
42. Simon HU, Plötz SG, Dummer R, Blaser K: Abnormal clones of T cells producing interleukin-5 in idiopathic eosinophilia. N Engl J Med 1999;341:1112-1120.
43. Gratzl S, Palca A, Schmitz M, Simon HU: Treatment with IFN-α in corticosteroid-unresponsive asthma. J Allergy Clin Immunol 2000;105:1035-1036.
44. Mueller O, Villiger B, O'Callaghan B, Simon HU: Immunological effects of competitive versus recreational sports in cross-country skiing. Int J Sports Med 2001;22:52-59.
45. 4-receptor antagonist, ICI 204,219, relieves symptoms of acute seasonal allergic rhinitis. Am J Respir Crit Care Med 1995;151:1734-1739.
46. Meltzer EO, Malmstrom K, Lu S, Prenner BM, Wie LX: Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: A randomized, placebo-controlled clinical trial. J Allergy Clin Immunol 2000;105:917-922.